PT3607962T - Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão - Google Patents

Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão

Info

Publication number
PT3607962T
PT3607962T PT191978667T PT19197866T PT3607962T PT 3607962 T PT3607962 T PT 3607962T PT 191978667 T PT191978667 T PT 191978667T PT 19197866 T PT19197866 T PT 19197866T PT 3607962 T PT3607962 T PT 3607962T
Authority
PT
Portugal
Prior art keywords
hypotension
angiotensin
alone
treatment
combination
Prior art date
Application number
PT191978667T
Other languages
English (en)
Portuguese (pt)
Original Assignee
The George Washington Univ A Congressionally Chartered Not For Profit Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53367119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3607962(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The George Washington Univ A Congressionally Chartered Not For Profit Corporation filed Critical The George Washington Univ A Congressionally Chartered Not For Profit Corporation
Publication of PT3607962T publication Critical patent/PT3607962T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT191978667T 2013-12-18 2014-12-18 Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão PT3607962T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US201461955706P 2014-03-19 2014-03-19

Publications (1)

Publication Number Publication Date
PT3607962T true PT3607962T (pt) 2025-11-18

Family

ID=53367119

Family Applications (2)

Application Number Title Priority Date Filing Date
PT148726847T PT2986308T (pt) 2013-12-18 2014-12-18 Angiotensina ii combinada para o tratamento de hipotensão
PT191978667T PT3607962T (pt) 2013-12-18 2014-12-18 Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT148726847T PT2986308T (pt) 2013-12-18 2014-12-18 Angiotensina ii combinada para o tratamento de hipotensão

Country Status (25)

Country Link
US (7) US9220745B2 (OSRAM)
EP (2) EP2986308B1 (OSRAM)
JP (4) JP6824739B2 (OSRAM)
KR (4) KR102399383B1 (OSRAM)
CN (4) CN119700926A (OSRAM)
AU (3) AU2014364528C1 (OSRAM)
BR (1) BR112016013961A2 (OSRAM)
CA (1) CA2933601A1 (OSRAM)
CY (1) CY1122604T1 (OSRAM)
DK (2) DK3607962T3 (OSRAM)
EA (1) EA037823B1 (OSRAM)
ES (1) ES2771749T3 (OSRAM)
FI (1) FI3607962T3 (OSRAM)
HR (1) HRP20200009T1 (OSRAM)
HU (1) HUE047062T2 (OSRAM)
IL (1) IL246162B (OSRAM)
LT (1) LT2986308T (OSRAM)
MX (2) MX380968B (OSRAM)
NZ (1) NZ721089A (OSRAM)
PL (1) PL2986308T3 (OSRAM)
PT (2) PT2986308T (OSRAM)
RS (1) RS59804B1 (OSRAM)
SI (1) SI2986308T1 (OSRAM)
SM (1) SMT202000018T1 (OSRAM)
WO (1) WO2015095535A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
HRP20200009T1 (hr) 2013-12-18 2020-03-20 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzin ii u kombinaciji za liječenje hipotenzije
CA2954016A1 (en) * 2014-07-08 2016-01-14 La Jolla Pharmaceutical Company Methods for treating hypotension
WO2016153558A1 (en) 2015-03-20 2016-09-29 Atkinson Arthur J Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
TW201733610A (zh) * 2016-01-07 2017-10-01 拉荷亞製藥公司 投與血管收縮素ｉｉ之方法
BR112018013852A2 (pt) * 2016-01-07 2018-12-18 La Jolla Pharmaceutical Company métodos de administração de vasopressores
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) * 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法
WO2023244552A1 (en) * 2022-06-15 2023-12-21 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
WO2024129057A1 (en) * 2022-12-12 2024-06-20 Proletariat Therapeutics, Inc. Methods of treating cardiac injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO2002098906A1 (en) 2001-06-04 2002-12-12 Human Genome Sciences, Inc. Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
JP2009510056A (ja) 2005-09-29 2009-03-12 ファイブローゲン、インコーポレーテッド 血圧を低下させる方法
EP1971358A4 (en) * 2005-12-30 2010-05-26 Florey Howard Inst Methods of Treatment
CA2655144A1 (en) 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
BRPI0719319A2 (pt) 2006-11-17 2014-02-04 Da Volterra Liberação colônica usando contas de zn/pectina com um revestimento de eudragit
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
JP2012510468A (ja) 2008-11-28 2012-05-10 アボット・ラボラトリーズ 安定な抗体組成物およびこれを安定させるための方法
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
EP2593541A4 (en) 2010-07-14 2014-01-22 Cumberland Emerging Technologies Inc METHOD FOR THE TREATMENT OF HEPATORENAL SYNDROME AND HEPATIC ENZEPHALOPATHY WITH THROMBOXANE A2 RECEPTOR ANTAGONISTS
WO2014176534A1 (en) 2013-04-26 2014-10-30 La Jolla Pharmaceutical Company Compositions and methods for treating renal failure
HRP20200009T1 (hr) 2013-12-18 2020-03-20 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzin ii u kombinaciji za liječenje hipotenzije
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
CA2954016A1 (en) * 2014-07-08 2016-01-14 La Jolla Pharmaceutical Company Methods for treating hypotension
BR112018013852A2 (pt) 2016-01-07 2018-12-18 La Jolla Pharmaceutical Company métodos de administração de vasopressores
TW201733610A (zh) 2016-01-07 2017-10-01 拉荷亞製藥公司 投與血管收縮素ｉｉ之方法
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法

Also Published As

Publication number Publication date
US10028995B2 (en) 2018-07-24
US20190328827A1 (en) 2019-10-31
US11096983B2 (en) 2021-08-24
EA201691258A1 (ru) 2016-11-30
AU2014364528B2 (en) 2020-08-27
KR20230051721A (ko) 2023-04-18
JP6824739B2 (ja) 2021-02-03
WO2015095535A9 (en) 2016-07-14
RS59804B1 (sr) 2020-02-28
NZ721089A (en) 2022-10-28
EP2986308A4 (en) 2017-01-11
WO2015095535A1 (en) 2015-06-25
JP2019214610A (ja) 2019-12-19
US20150164980A1 (en) 2015-06-18
AU2014364528A1 (en) 2016-06-30
JP7175506B2 (ja) 2022-11-21
US20160129072A1 (en) 2016-05-12
ES2771749T3 (es) 2020-07-07
JP2022137224A (ja) 2022-09-21
JP2025114753A (ja) 2025-08-05
US20190070250A1 (en) 2019-03-07
US10493124B2 (en) 2019-12-03
PT2986308T (pt) 2020-01-21
FI3607962T3 (fi) 2025-11-24
KR20160117437A (ko) 2016-10-10
IL246162B (en) 2020-03-31
IL246162A0 (en) 2016-07-31
CN112546197A (zh) 2021-03-26
SMT202000018T1 (it) 2020-03-13
MX380968B (es) 2025-03-12
EP2986308B1 (en) 2019-10-16
LT2986308T (lt) 2020-03-25
AU2014364528A9 (en) 2016-07-28
AU2020277230A1 (en) 2020-12-24
EP3607962B1 (en) 2025-08-13
HUE047062T2 (hu) 2020-04-28
CA2933601A1 (en) 2015-06-25
US20230226141A1 (en) 2023-07-20
CN106061493A (zh) 2016-10-26
CN111920939A (zh) 2020-11-13
MX2016008108A (es) 2017-03-09
KR20240154702A (ko) 2024-10-25
HRP20200009T1 (hr) 2020-03-20
JP2017501154A (ja) 2017-01-12
CY1122604T1 (el) 2021-03-12
AU2024219851A1 (en) 2024-10-10
US11559559B2 (en) 2023-01-24
KR20220028125A (ko) 2022-03-08
AU2014364528C1 (en) 2021-01-07
US10765722B2 (en) 2020-09-08
EP2986308A1 (en) 2016-02-24
DK2986308T3 (en) 2020-01-27
CN119700926A (zh) 2025-03-28
KR102399383B1 (ko) 2022-05-19
US20180193407A1 (en) 2018-07-12
US20220047669A1 (en) 2022-02-17
DK3607962T3 (da) 2025-11-17
PL2986308T3 (pl) 2020-05-18
MX2020011190A (es) 2020-11-13
BR112016013961A2 (pt) 2017-10-10
EP3607962A1 (en) 2020-02-12
SI2986308T1 (sl) 2020-03-31
US9220745B2 (en) 2015-12-29
EA037823B1 (ru) 2021-05-25

Similar Documents

Publication Publication Date Title
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
GB201321743D0 (en) Therapeutic agents
GB201321738D0 (en) Therapeutic Agents
IL246162A0 (en) Angiotensin II, alone or in combination, to treat low blood pressure
GB201321729D0 (en) Therapeutic agents
IL244014A0 (en) Combined therapy for the treatment of glioblastoma
GB201321728D0 (en) Therapeutic agents
GB201321733D0 (en) Therapeutic agents
GB201321739D0 (en) Therapeutic agents
GB201321730D0 (en) Therapeutic agents
GB201321741D0 (en) Therapeutic agents
GB201321740D0 (en) Therapeutic agents
GB201321732D0 (en) Therapeutic agents
GB201321744D0 (en) Therapeutic agents
GB201321737D0 (en) Therapeutic Agents
GB201321742D0 (en) Therapeutic agents
GB201321735D0 (en) Therapeutic Agents
GB201321745D0 (en) Therapeutic agents
GB201321731D0 (en) Therapeutic agents
GB201304872D0 (en) Treatment
GB201317960D0 (en) Water treatment
GB201302839D0 (en) Water Treatment
GB201307310D0 (en) Treatment
ZA201604412B (en) Water treatment